Cargando…
Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis
Systemic sclerosis and autoimmune myositis are both associated with decreased quality of life and increased mortality. Their prognosis and management largely depend on the disease subgroups. Indeed, systemic sclerosis is a heterogeneous disease, the two predominant forms of the disease being limited...
Autores principales: | Giannini, Margherita, Ellezam, Benjamin, Leclair, Valérie, Lefebvre, Frédéric, Troyanov, Yves, Hudson, Marie, Senécal, Jean-Luc, Geny, Bernard, Landon-Cardinal, Océane, Meyer, Alain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910219/ https://www.ncbi.nlm.nih.gov/pubmed/36776390 http://dx.doi.org/10.3389/fimmu.2022.974078 |
Ejemplares similares
-
Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype
por: Troyanov, Yves, et al.
Publicado: (2017) -
Scleromyositis: A Novel Entity Beyond Systemic Sclerosis and Autoimmune Myositis
por: Marche Fernandez, Osvaldo Alexis, et al.
Publicado: (2023) -
Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies
por: Landon-Cardinal, Océane, et al.
Publicado: (2020) -
Myositis with prominent B-cell aggregates causing shrinking lung syndrome in systemic lupus erythematosus: a case report
por: Roy, Flavie, et al.
Publicado: (2022) -
Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes
por: Koenig, Martial, et al.
Publicado: (2007)